Guest blog by Moheb Costandi.
In November, some of the world’s leading bioethicists and neuroscientists will convene in San Diego for the annual meeting of the International Neuroethics Society (INS).
The 2016 meeting marks the tenth anniversary of the INS. In that time, we have seen unprecedented advances in neuroscience and, consequently, a plethora of new technologies developed to further our understanding of the brain, and to fix it when it goes wrong, have emerged.
Even so, our understanding of this complex organ is far from complete. We still know very little about the causes of Alzheimer’s disease, for example, and it is widely believed that the incidence of this debilitating neurodegenerative condition will reach epidemic proportions in the years to come. Similarly, the global burden of mental health issues is expected to grow, and has been projected to affect 15% of the world’s population by the year 2020–disabling more people than AIDS, heart disease, traffic accidents, and wars combined.
Faced with these grim prospects, the U.S., Europe, China, Japan, and other countries have launched, or are set to launch, national large-scale neuroscience initiatives. Leading figures from some of these initiatives will discuss their country’s brain research efforts and the ethical issues they raise in a panel discussion and breakout sessions at the INS meeting.